Status:
WITHDRAWN
Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Epidermolysis Bullosa
Eligibility:
All Genders
13-60 years
Phase:
PHASE4
Brief Summary
Epidermolysis Bullosa(EB) is an inherited bullous disease. Tetracycline is believed to have anti inflammatory properties. 20 patients with EB older than 13 years will be treated for 4 months with tetr...
Detailed Description
Epidermolysis Bullosa(EB) is an inherited bullous disease. Tetracycline is believed to have anti inflammatory properties. 20 patients with EB older than 13 years will be treated for 4 months with tetr...
Eligibility Criteria
Inclusion
- diagnosed as epidermolysis bullosa
- not pregnant
- active disease
- more than 5 bulla-
Exclusion
- age less than 13
- known sensitivity to tetracyclin
- abnormal liver and kidney tests.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00336154
Last Update
October 28 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.